These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37488242)
1. Identification of c-Met as a novel target of γ-glutamylcyclotransferase. Saito Y; Taniguchi K; Ii H; Horinaka M; Kageyama S; Nakata S; Ukimura O; Sakai T Sci Rep; 2023 Jul; 13(1):11922. PubMed ID: 37488242 [TBL] [Abstract][Full Text] [Related]
2. Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis. Taniguchi K; Ii H; Kageyama S; Takagi H; Chano T; Kawauchi A; Nakata S Biochem Biophys Res Commun; 2019 Sep; 517(2):238-243. PubMed ID: 31345573 [TBL] [Abstract][Full Text] [Related]
3. Administration of Gapmer-type Antisense Oligonucleotides Targeting γ-Glutamylcyclotransferase Suppresses the Growth of A549 Lung Cancer Xenografts. Ii H; Kasahara Y; Yamaguma H; Kageyama S; Kawauchi A; Obika S; Nakata S Anticancer Res; 2022 Mar; 42(3):1221-1227. PubMed ID: 35220212 [TBL] [Abstract][Full Text] [Related]
4. Desert Hedgehog Down-regulation Mediates Inhibition of Proliferation by γ-Glutamylcyclotransferase Knockdown in Murine Glioblastoma Stem Cells. Mori M; Ii H; Fujita M; Nose K; Shimada A; Shiraki R; Sone Y; Moyama C; Taniguchi K; Nakata S Cancer Genomics Proteomics; 2024; 21(5):474-484. PubMed ID: 39191500 [TBL] [Abstract][Full Text] [Related]
5. γ-Glutamylcyclotransferase Knockdown Inhibits Growth of Lung Cancer Cells Through G0/G1 Phase Arrest. Lin Z; Xiong L; Zhou J; Wang J; Li Z; Hu H; Lin Q Cancer Biother Radiopharm; 2015 Jun; 30(5):211-6. PubMed ID: 25941902 [TBL] [Abstract][Full Text] [Related]
6. Depletion of gamma-glutamylcyclotransferase in cancer cells induces autophagy followed by cellular senescence. Taniguchi K; Matsumura K; Ii H; Kageyama S; Ashihara E; Chano T; Kawauchi A; Yoshiki T; Nakata S Am J Cancer Res; 2018; 8(4):650-661. PubMed ID: 29736310 [TBL] [Abstract][Full Text] [Related]
7. Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation. Matsumura K; Nakata S; Taniguchi K; Ii H; Ashihara E; Kageyama S; Kawauchi A; Yoshiki T BMC Cancer; 2016 Sep; 16(1):748. PubMed ID: 27658708 [TBL] [Abstract][Full Text] [Related]
8. A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer. Ii H; Yoshiya T; Nakata S; Taniguchi K; Hidaka K; Tsuda S; Mochizuki M; Nishiuchi Y; Tsuda Y; Ito K; Kageyama S; Yoshiki T ChemMedChem; 2018 Jan; 13(2):155-163. PubMed ID: 29316360 [TBL] [Abstract][Full Text] [Related]
9. Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells. Takagi H; Ii H; Kageyama S; Hanada E; Taniguchi K; Yoshiya T; Chano T; Kawauchi A; Nakata S Anticancer Res; 2019 Sep; 39(9):4811-4816. PubMed ID: 31519583 [TBL] [Abstract][Full Text] [Related]
10. γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis. Taniguchi K; Kageyama S; Moyama C; Ando S; Ii H; Ashihara E; Horinaka M; Sakai T; Kubota S; Kawauchi A; Nakata S Cancer Gene Ther; 2022 Jan; 29(1):37-48. PubMed ID: 33402732 [TBL] [Abstract][Full Text] [Related]
11. γ-Glutamylcyclotransferase is transcriptionally regulated by c-Jun and controls proliferation of glioblastoma stem cells through Notch1 levels. Nose K; Taniguchi K; Fujita M; Moyama C; Mori M; Ishita M; Yoshida T; Ii H; Sakai T; Nakata S Cancer Gene Ther; 2024 Dec; 31(12):1831-1839. PubMed ID: 39394529 [TBL] [Abstract][Full Text] [Related]
12. Identification of U83836E as a γ-glutamylcyclotransferase inhibitor that suppresses MCF7 breast cancer xenograft growth. Ii H; Nohara Y; Yoshiya T; Masuda S; Tsuda S; Oishi S; Friedman J; Kawabe T; Nakata S Biochem Biophys Res Commun; 2021 Apr; 549():128-134. PubMed ID: 33676180 [TBL] [Abstract][Full Text] [Related]
13. Prohibitin-2 is a novel regulator of p21 Taniguchi K; Matsumura K; Kageyama S; Ii H; Ashihara E; Chano T; Kawauchi A; Yoshiki T; Nakata S Biochem Biophys Res Commun; 2018 Jan; 496(1):218-224. PubMed ID: 29307834 [TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamylcyclotransferase promotes the growth of human glioma cells by activating Notch-Akt signaling. Shen SH; Yu N; Liu XY; Tan GW; Wang ZX Biochem Biophys Res Commun; 2016 Mar; 471(4):616-20. PubMed ID: 26828272 [TBL] [Abstract][Full Text] [Related]
15. miR-877 inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting gamma-glutamylcyclotransferase. Jia C; Gao J; Wang L; Li Z; Dong Z; Yao L; Yao X Endocr J; 2021 Sep; 68(9):1109-1116. PubMed ID: 34121038 [TBL] [Abstract][Full Text] [Related]
16. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway. Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592 [TBL] [Abstract][Full Text] [Related]
17. Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer. Zhang HM; Li ZY; Dai ZT; Wang J; Li LW; Zong QB; Li JP; Zhang TC; Liao XH Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233293 [TBL] [Abstract][Full Text] [Related]
18. Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment. Kageyama S; Hanada E; Ii H; Tomita K; Yoshiki T; Kawauchi A Biomed Res Int; 2015; 2015():345219. PubMed ID: 26339607 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy. Kageyama S; Ii H; Taniguchi K; Kubota S; Yoshida T; Isono T; Chano T; Yoshiya T; Ito K; Yoshiki T; Kawauchi A; Nakata S Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011933 [TBL] [Abstract][Full Text] [Related]
20. Myc upregulates Ggct, γ-glutamylcyclotransferase to promote development of p53-deficient osteosarcoma. Ueno T; Otani S; Date Y; Katsuma Y; Nagayoshi Y; Ito T; Ii H; Kageyama S; Nakata S; Ito K Cancer Sci; 2024 Sep; 115(9):2961-2971. PubMed ID: 38924236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]